Plate Nº 98 · recorded October 2, 2026
Health & Medicine ResearchReported finding
Pharmacy Closures Hit Minority Communities Hardest, Study Finds
A nationwide study finds predominantly white neighborhoods have 15% more pharmacies per 10,000 people than minority communities, with race a stronger factor than income.
By Priya Raman4 min read802 words
In brief
- Nearly one in three US pharmacies closed between 2010 and 2021, including more than 7,000 since 2019.
- Predominantly white neighborhoods had 15% more pharmacies per 10,000 people than predominantly minority neighborhoods, both before and after the COVID-19 pandemic.
- In minority communities, median household income was nearly the same in areas with and without pharmacies, suggesting race and ethnicity may matter more than income.
Pharmacies in the United States are closing at a rapid pace, and the burden is falling disproportionately on racial and ethnic minority communities. That is the central finding of a new nationwide study led by researchers at Boston University School of Public Health (BUSPH), published in JAMA Network Open.
The scale of the problem is already large. Past research indicates that nearly one in three pharmacies closed between 2010 and 2021, including more than 7,000 pharmacies since 2019. The closures leave millions of Americans in what researchers call "pharmacy deserts" — areas where residents lack convenient and reasonable access to pharmacy services.
The new study adds a sharper demographic picture. Analyzing data from more than 112,000 census block groups across 45 states and Washington, D.C., the researchers found that predominantly white neighborhoods had 15% more pharmacies per 10,000 people than neighborhoods with predominantly minority populations. This gap existed both before the COVID-19 pandemic, from January 2019 to January 2020, and after its acute phase, from January 2023 to January 2024.
Race appears to matter more than income
A census block group is a small geographic unit used by the U.S. Census Bureau, typically home to a few hundred to a few thousand people — small enough to reflect a single neighborhood.
One of the study's most striking findings concerns income. Predominantly white and diverse neighborhoods with at least one pharmacy had a higher median household income than neighborhoods with none. But in neighborhoods where racial and ethnic minority residents formed the majority, the median household income was nearly the same whether a pharmacy was present or not. This pattern suggests that race and ethnicity might be a stronger determinant of whether a neighborhood becomes a pharmacy desert than income alone.
The analysis also linked other neighborhood characteristics to pharmacy availability. Vehicle ownership, the percentage of single-family homes and median age were associated with an increase in pharmacies per 10,000 people. The percentage of females, higher median household income and the percentage of residents born outside the U.S. were associated with a decrease.
Tracking visits through mobile devices
To understand how people actually use pharmacies, the researchers tracked anonymized movement data from mobile phones. They found that people in predominantly white communities most often visited pharmacies in similar, largely white neighborhoods. Residents of minority communities with fewer pharmacies, by contrast, tended to travel to more diverse neighborhoods to fill prescriptions and access other pharmacy services.
"Our findings show that individuals from predominantly Black and other racial minority areas might prefer to visit pharmacies in diverse neighborhoods if they do not have an available pharmacy," said Dr. Elaine Nsoesie, the study's lead author and an associate professor of global health at BUSPH. She began investigating pharmacy access after writing a 2024 opinion piece in The Boston Globe about pharmacy deserts in Black and Latino communities, which drew a wide range of responses from readers.
Closures affect more than medication pickup
Pharmacies have evolved over recent decades from simple dispensing counters into trusted community health hubs, offering vaccines, testing and treatment for a range of conditions. When a pharmacy closes — or never existed — residents lose access to all of these services at once.
"When a pharmacy is absent in a neighborhood because it closed or was never there, this can create barriers for residents to obtain not only medications but also other essential health services such as vaccines, testing and treatment for multiple diseases and conditions, and other health services," Nsoesie said.
Past data indicate that pharmacy closures have already led to declines in both access to and adherence to lifesaving medications, including cardiovascular drugs and anticonvulsants, which are used to control seizures.
What could fix it
The researchers point to a combination of causes behind the closures: thin profit margins, reduced reimbursement rates for medications and a workforce shortage. Fixing the problem, they argue, will likely require pairing financial reforms with practical local measures.
"Researchers have written about the need to develop policies and financing programs that encourage pharmacies to be located in pharmacy deserts," Nsoesie said. "We suggest that such policies could be coupled with affordable and accessible transportation. However, any long-term solutions should consider the specific needs of the local community to ensure that solutions are effective."
The study's co-authors include Andrew Philips, a research fellow at BUSPH at the time of the study; Dr. Nina Cesare, a research scientist in the Biostatistics and Epidemiology Data Analytics Center at BUSPH; and Zou Yang, then a Ph.D. student at Dartmouth College's Thayer School of Engineering. The analysis relies on mobile device mobility data, which may not capture every population group equally — one limitation the researchers say future work should keep in mind as the pharmacy landscape continues to shift.
via Medical Xpress (Source)
More from Priya Raman
Show full bio
Senior reporter covering industry trends and analytics at SciBeat.
57 articles
Nearby plates
- FDA Urges Drug Makers to Release Data From Thousands of Unpublished Trials
- Cychlorphine: A New Opioid Up to 10 Times Stronger Than Fentanyl
- New CHEST Guideline Targets Smoking Treatment in Hospitalized Patients
- Pediatric Kidney Injury Hospitalizations Rose Tenfold Since 1997
- Survey of NIH-Funded Scientists Points to a Shaky U.S. Research Enterprise